Women younger than 70 have a relatively low risk of abnormal growth in the upper part of the colon - suggesting, U.S. researchers say, that many women can opt for less invasive colon cancer screening.

The first blood test to screen for colorectal cancer could be approved this year — raising the potential to drastically increase the number of people diagnosed with the second-highest cause of cancer ...

Cancer of the colon and rectum is the third most common cancer in the U.S., and the second deadliest. Every year, 150,000 new cases are diagnosed nationally and over 50,000 people die from colorectal ...

TUESDAY, April 24, 2018 -- Sigmoidoscopy, an alternative to colonoscopy, may help one gender more than the other, new research shows. Flexible sigmoidoscopy looks at about a third of the colon, as ...

One of the deadliest cancers in the United States can now be detected in the privacy of your own home. Exact Sciences Corp. (NASDAQ:EXAS) has created Cologuard to screen for colon cancer, the second ...

PHOENIX – An Arizona company has a new colon cancer blood test on the market that sounds like an enticing alternative to the oft-dreaded colonoscopy. The $170 blood test, called BeScreened-CRC, was ...

The former Today co-host is giving PEOPLE the first look at the new Cologuard TV commercial, which is part of her Mission to Screen campaign Based in Los Angeles, Marissa is an award-winning ...

Convincing patients to do an often dreaded colon cancer screening test could just take a little extra nudge – like a chance to win $50. Patients who were told they had a 1-in-10 chance of winning $50 ...

When it comes to colon cancer, the most popular strategy for screening is the colonoscopy, which involves a nearly 24-hour commitment to the prep for the invasive and uncomfortable procedure. The ...

Oct 22 (Reuters) - Women younger than 70 have a relatively low risk of abnormal growth in the upper part of the colon - suggesting, U.S. researchers say, that many women can opt for less invasive ...